1013 related articles for article (PubMed ID: 25000539)
21. Graphene oxide/manganese ferrite nanohybrids for magnetic resonance imaging, photothermal therapy and drug delivery.
Yang Y; Shi H; Wang Y; Shi B; Guo L; Wu D; Yang S; Wu H
J Biomater Appl; 2016 Jan; 30(6):810-22. PubMed ID: 26296777
[TBL] [Abstract][Full Text] [Related]
22. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations.
Liu G; Shen H; Mao J; Zhang L; Jiang Z; Sun T; Lan Q; Zhang Z
ACS Appl Mater Interfaces; 2013 Aug; 5(15):6909-14. PubMed ID: 23883622
[TBL] [Abstract][Full Text] [Related]
23. Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy.
Bai J; Liu Y; Jiang X
Biomaterials; 2014 Jul; 35(22):5805-13. PubMed ID: 24767788
[TBL] [Abstract][Full Text] [Related]
24. Fabrication and characterization of a triple functionalization of graphene oxide with Fe3O4, folic acid and doxorubicin as dual-targeted drug nanocarrier.
Wang Z; Zhou C; Xia J; Via B; Xia Y; Zhang F; Li Y; Xia L
Colloids Surf B Biointerfaces; 2013 Jun; 106():60-5. PubMed ID: 23434692
[TBL] [Abstract][Full Text] [Related]
25. Tracking the intracellular drug release from graphene oxide using surface-enhanced Raman spectroscopy.
Huang J; Zong C; Shen H; Cao Y; Ren B; Zhang Z
Nanoscale; 2013 Nov; 5(21):10591-8. PubMed ID: 24057012
[TBL] [Abstract][Full Text] [Related]
26. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
27. Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery.
Hu H; Yu J; Li Y; Zhao J; Dong H
J Biomed Mater Res A; 2012 Jan; 100(1):141-8. PubMed ID: 21997951
[TBL] [Abstract][Full Text] [Related]
28. Hyaluronic acid nanogels prepared via ortho ester linkages show pH-triggered behavior, enhanced penetration and antitumor efficacy in 3-D tumor spheroids.
Yang G; Fu S; Yao W; Wang X; Zha Q; Tang R
J Colloid Interface Sci; 2017 Oct; 504():25-38. PubMed ID: 28527297
[TBL] [Abstract][Full Text] [Related]
29. Controlled release of doxorubicin from electrospun PEO/chitosan/graphene oxide nanocomposite nanofibrous scaffolds.
Ardeshirzadeh B; Anaraki NA; Irani M; Rad LR; Shamshiri S
Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():384-90. PubMed ID: 25579938
[TBL] [Abstract][Full Text] [Related]
30. Self-assembled graphene-dextran nanohybrid for killing drug-resistant cancer cells.
Jin R; Ji X; Yang Y; Wang H; Cao A
ACS Appl Mater Interfaces; 2013 Aug; 5(15):7181-9. PubMed ID: 23875578
[TBL] [Abstract][Full Text] [Related]
31. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
[TBL] [Abstract][Full Text] [Related]
32. Carboxymethyl cellulose/graphene oxide bio-nanocomposite hydrogel beads as anticancer drug carrier agent.
Rasoulzadeh M; Namazi H
Carbohydr Polym; 2017 Jul; 168():320-326. PubMed ID: 28457456
[TBL] [Abstract][Full Text] [Related]
33. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
34. Multifunctional nanocomposite based on graphene oxide for in vitro hepatocarcinoma diagnosis and treatment.
Shen AJ; Li DL; Cai XJ; Dong CY; Dong HQ; Wen HY; Dai GH; Wang PJ; Li YY
J Biomed Mater Res A; 2012 Sep; 100(9):2499-506. PubMed ID: 22623284
[TBL] [Abstract][Full Text] [Related]
35. Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery.
Han HS; Thambi T; Choi KY; Son S; Ko H; Lee MC; Jo DG; Chae YS; Kang YM; Lee JY; Park JH
Biomacromolecules; 2015 Feb; 16(2):447-56. PubMed ID: 25565417
[TBL] [Abstract][Full Text] [Related]
36. Galactosylated chitosan-grafted multiwall carbon nanotubes for pH-dependent sustained release and hepatic tumor-targeted delivery of doxorubicin in vivo.
Qi X; Rui Y; Fan Y; Chen H; Ma N; Wu Z
Colloids Surf B Biointerfaces; 2015 Sep; 133():314-22. PubMed ID: 26123852
[TBL] [Abstract][Full Text] [Related]
37. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ
Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132
[TBL] [Abstract][Full Text] [Related]
38. Hyaluronic acid-modified, IR780-conjugated and doxorubicin-loaded reduced graphene oxide for targeted cancer chemo/photothermal/photodynamic therapy.
Dash BS; Lu YJ; Pejrprim P; Lan YH; Chen JP
Biomater Adv; 2022 May; 136():212764. PubMed ID: 35929292
[TBL] [Abstract][Full Text] [Related]
39. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
[TBL] [Abstract][Full Text] [Related]
40. pH-Responsive Hyaluronic Acid-Based Mixed Micelles for the Hepatoma-Targeting Delivery of Doxorubicin.
Wu JL; Tian GX; Yu WJ; Jia GT; Sun TY; Gao ZQ
Int J Mol Sci; 2016 Mar; 17(4):364. PubMed ID: 27043540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]